Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease

Background: The substrates for arrhythmias in myocarditis and ischemic heart disease (IHD) are different, but it is yet to be determined whether there is a difference in outcomes following catheter ablation (CA) for ventricular tachycardia (VT) associated with these two conditions...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheng Su, Le Li, Xi Peng, Likun Zhou, Zhuxin Zhang, Yulong Xiong, Zhenhao Zhang, Mengtong Xu, Yan Yao
Format: Article
Language:English
Published: IMR Press 2025-01-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25604
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586513904304128
author Sheng Su
Le Li
Xi Peng
Likun Zhou
Zhuxin Zhang
Yulong Xiong
Zhenhao Zhang
Mengtong Xu
Yan Yao
author_facet Sheng Su
Le Li
Xi Peng
Likun Zhou
Zhuxin Zhang
Yulong Xiong
Zhenhao Zhang
Mengtong Xu
Yan Yao
author_sort Sheng Su
collection DOAJ
description Background: The substrates for arrhythmias in myocarditis and ischemic heart disease (IHD) are different, but it is yet to be determined whether there is a difference in outcomes following catheter ablation (CA) for ventricular tachycardia (VT) associated with these two conditions. This study aimed to compare outcomes after CA of VT in patients with myocarditis versus those with IHD. Methods: Patients undergoing CA for sustained VT confirmed by endomyocardial biopsy as myocarditis, and patients with IHD experiencing sustained VT undergoing CA were retrospectively enrolled from February 2017 to March 2023. Initially, an endocardial approach was employed, reserving epicardial ablation procedures for non-responders. The primary endpoint was VT recurrence during follow up. All-cause mortality, repeat CA for VT and implantable cardioverter-defibrillator (ICD) implantation served as secondary endpoints. Kaplan-Meier curves compared outcomes between patient groups. Results: This study included 109 patients with IHD and 20 patients with myocarditis who underwent CA for sustained VT, from February 2017 to March 2023. Compared with IHD patients, myocarditis patients had a statistically significant lower complete short-term success rate of CA (60.0% vs. 85.3%, p = 0.013). During a follow-up period of 37 ± 21 months, 8 (40.0%) myocarditis patients experienced VT recurrence compared to 57 (52.3%) IHD patients, with no statistically significant difference between the two groups. During follow-up, 2 (10.0%) myocarditis patients died and 2 (10.0%) underwent repeat CA for VT recurrence, while 9 (8.3%) IHD patients died, 14 (12.8%) underwent a second CA for VT recurrence, and 8 (7.3%) received an ICD implantation. Additionally, there were no notable variations between the two groups regarding all-cause mortality, repeat CA for VT and ICD implantation. Conclusions: It was demonstrated that the efficacy of CA in sustained VT in myocarditis patients was similar to that in IHD. For myocarditis patients with VT, CA might be equally effective.
format Article
id doaj-art-721c0e5c53544c3ea0992186f39c9dff
institution Kabale University
issn 1530-6550
language English
publishDate 2025-01-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj-art-721c0e5c53544c3ea0992186f39c9dff2025-01-25T10:41:19ZengIMR PressReviews in Cardiovascular Medicine1530-65502025-01-012612560410.31083/RCM25604S1530-6550(24)01571-0Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart DiseaseSheng Su0Le Li1Xi Peng2Likun Zhou3Zhuxin Zhang4Yulong Xiong5Zhenhao Zhang6Mengtong Xu7Yan Yao8Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaArrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 100037 Beijing, ChinaBackground: The substrates for arrhythmias in myocarditis and ischemic heart disease (IHD) are different, but it is yet to be determined whether there is a difference in outcomes following catheter ablation (CA) for ventricular tachycardia (VT) associated with these two conditions. This study aimed to compare outcomes after CA of VT in patients with myocarditis versus those with IHD. Methods: Patients undergoing CA for sustained VT confirmed by endomyocardial biopsy as myocarditis, and patients with IHD experiencing sustained VT undergoing CA were retrospectively enrolled from February 2017 to March 2023. Initially, an endocardial approach was employed, reserving epicardial ablation procedures for non-responders. The primary endpoint was VT recurrence during follow up. All-cause mortality, repeat CA for VT and implantable cardioverter-defibrillator (ICD) implantation served as secondary endpoints. Kaplan-Meier curves compared outcomes between patient groups. Results: This study included 109 patients with IHD and 20 patients with myocarditis who underwent CA for sustained VT, from February 2017 to March 2023. Compared with IHD patients, myocarditis patients had a statistically significant lower complete short-term success rate of CA (60.0% vs. 85.3%, p = 0.013). During a follow-up period of 37 ± 21 months, 8 (40.0%) myocarditis patients experienced VT recurrence compared to 57 (52.3%) IHD patients, with no statistically significant difference between the two groups. During follow-up, 2 (10.0%) myocarditis patients died and 2 (10.0%) underwent repeat CA for VT recurrence, while 9 (8.3%) IHD patients died, 14 (12.8%) underwent a second CA for VT recurrence, and 8 (7.3%) received an ICD implantation. Additionally, there were no notable variations between the two groups regarding all-cause mortality, repeat CA for VT and ICD implantation. Conclusions: It was demonstrated that the efficacy of CA in sustained VT in myocarditis patients was similar to that in IHD. For myocarditis patients with VT, CA might be equally effective.https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25604catheter ablationsustained ventricular tachycardiaoutcomemyocarditisischemic heart disease
spellingShingle Sheng Su
Le Li
Xi Peng
Likun Zhou
Zhuxin Zhang
Yulong Xiong
Zhenhao Zhang
Mengtong Xu
Yan Yao
Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
Reviews in Cardiovascular Medicine
catheter ablation
sustained ventricular tachycardia
outcome
myocarditis
ischemic heart disease
title Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
title_full Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
title_fullStr Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
title_full_unstemmed Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
title_short Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
title_sort outcomes in catheter ablation of sustained ventricular tachycardia in myocarditis compared with ischemic heart disease
topic catheter ablation
sustained ventricular tachycardia
outcome
myocarditis
ischemic heart disease
url https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25604
work_keys_str_mv AT shengsu outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT leli outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT xipeng outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT likunzhou outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT zhuxinzhang outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT yulongxiong outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT zhenhaozhang outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT mengtongxu outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease
AT yanyao outcomesincatheterablationofsustainedventriculartachycardiainmyocarditiscomparedwithischemicheartdisease